Literature DB >> 12766479

Apoptosis staining in cultured pseudoachondroplasia chondrocytes.

J Duke1, D Montufar-Solis, S Underwood, Z Lalani, J T Hecht.   

Abstract

Pseudoachondroplasia (PSACH) is a skeletal dysplasia caused by a mutation in cartilage oligomeric matrix protein (COMP), a glycoprotein of normal cartilage matrix. PSACH chondrocytes have a distinctive phenotype with enlarged rER cisternae containing COMP, aggrecan, type IX collagen, and chaperone proteins. Ultrastructural studies suggested that this accumulation compromises cell function, hastening cell death, and consequently reducing the number of cells in the growth plate contributing to linear bone growth. Using the alginate bead system, we cultured control and PSACH chondrocytes for twenty weeks and one year to determine the effect of the mutation on size and number of cartilage nodules; and the presence of apoptotic cell death (TUNEL assay). At 20 weeks, beads containing PSACH or control chondrocytes did not differ in size and number of cartilage nodules or number of TUNEL-positive cells. After one year, nodule number, size and percent cartilage per bead were significantly less in PSACH nodules, and the number of cells staining positive for apoptosis was significantly greater than in controls (71.8% vs. 44.6%). The increase in apoptosis in PSACH nodules correlates with a decrease in growth of cartilage, supporting our hypothesis that death of damaged cells contributes to the growth plate defects in PSACH.

Entities:  

Mesh:

Year:  2003        PMID: 12766479     DOI: 10.1023/a:1022926811397

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  18 in total

1.  Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis.

Authors:  Francoise Coustry; Karen L Posey; Tristan Maerz; Kevin Baker; Annie M Abraham; Catherine G Ambrose; Sabah Nobakhti; Sandra J Shefelbine; Xiaohong Bi; Michael Newton; Karissa Gawronski; Lindsay Remer; Alka C Veerisetty; Mohammad G Hossain; Frankie Chiu; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-01-05       Impact factor: 11.583

2.  Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies.

Authors:  Karen L Posey; Francoise Coustry; Alka C Veerisetty; Mohammad G Hossain; Michael J Gambello; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

3.  Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia.

Authors:  Karen L Posey; Francoise Coustry; Alka C Veerisetty; Peiman Liu; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2011-12-07       Impact factor: 4.307

4.  D469del-COMP retention in chondrocytes stimulates caspase-independent necroptosis.

Authors:  Françoise Coustry; Karen L Posey; Peiman Liu; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2011-12-07       Impact factor: 4.307

5.  ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.

Authors:  Chuan-Ju Liu; Wei Kong; Kiril Ilalov; Shuang Yu; Ke Xu; Lisa Prazak; Marc Fajardo; Bantoo Sehgal; Paul E Di Cesare
Journal:  FASEB J       Date:  2006-04-03       Impact factor: 5.191

6.  Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.

Authors:  Joseph L Alcorn; Thomas M Merritt; Mary C Farach-Carson; Huiqui H Wang; Jacqueline T Hecht
Journal:  RNA       Date:  2009-02-23       Impact factor: 4.942

7.  Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3.

Authors:  Sally L Cotterill; Gail C Jackson; Matthew P Leighton; Raimund Wagener; Outi Mäkitie; William G Cole; Michael D Briggs
Journal:  Hum Mutat       Date:  2005-12       Impact factor: 4.878

8.  An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.

Authors:  Karen L Posey; Alka C Veerisetty; Pieman Liu; Huiqiu R Wang; Brian J Poindexter; Roger Bick; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

9.  Mutations targeting intermodular interfaces or calcium binding destabilize the thrombospondin-2 signature domain.

Authors:  C Britt Carlson; Kristin A Gunderson; Deane F Mosher
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

Review 10.  The unfolded protein response and its relevance to connective tissue diseases.

Authors:  Raymond P Boot-Handford; Michael D Briggs
Journal:  Cell Tissue Res       Date:  2009-10-23       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.